Building for What Comes Next: Robust Process Development and Analytical Strategies in Early Pharmaceutical Development
12.04.2026
Successful drug development depends on the seamless integration of early process development and analytical development to establish the foundation for commercial success. Aligning process and analytical strategies from the earliest stages of development enables more informed decision-making, accelerates process understanding and reduces technical and regulatory risks as programs progress.
Join this live webinar in which Cambrex experts will highlight industry best practices, proven approaches and lessons learned for fostering effective collaboration between process development and analytical teams throughout the development lifecycle. Through real-world case studies, the discussion will demonstrate how an integrated approach to early development can improve efficiency, enhance process robustness and establish a stronger scientific foundation for scale-up, technology transfer and commercial manufacturing. Attendees will learn how these insights can help drive process optimization, mitigate development risks and increase the probability of successful commercialization.
Key Takeaways:
- How integrated process and analytical strategies can reveal risks before they constrain manufacturing or development decisions
- Where external expertise can add the greatest value before technical challenges become urgent